SECUKINUMAB

Secukinumab is an IL-17A monoclonal antibody for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Side effects include infections, diarrhea, nasopharyngitis, and rare inflammatory bowel disease exacerbation.

SKU: d1f2322b418c Category: Tag:

Product Description


Mechanism of Action

SECUKINUMAB (ID 27431) displays a multidimensional biochemical activity profile integrating modulation of enzymatic pathways, receptor‑mediated signalling, mitochondrial bioenergetics, oxidative‑stress homeostasis, ion‑channel dynamics, membrane structural behaviour and transcription‑factor regulation. Structural modelling suggests interactions with catalytic residues, allosteric microdomains, transmembrane helices, signalling cofactors and cytoskeletal complexes. These interactions enable influence over phosphorylation cascades, second‑messenger flux (Ca²⁺, IP₃, DAG, cAMP), ROS balance, ATP turnover, membrane‑potential stability and organelle stress‑response thresholds.

Benefits and Applications

  • Receptor–ligand affinity analysis and docking studies
  • Enzyme‑kinetic profiling and catalytic‑flux pathway mapping
  • Mitochondrial‑function modelling and ATP/ROS system evaluation
  • Transcriptomic, metabolomic, proteomic and phosphoproteomic profiling
  • Cytoskeletal‑architecture and membrane‑dynamics exploration
  • Apoptosis, autophagy, necroptosis and ferroptosis pathway modelling
  • SAR/QSAR modelling and compound‑optimisation workflows
  • Mechanistic pharmacodynamics and dose–response simulation

Side Effects and Risks

  • Oxidative‑stress imbalance and elevated ROS
  • Mitochondrial overload or respiratory‑chain suppression
  • Disruption of Ca²⁺/Na⁺/K⁺ ion‑homeostasis
  • Unintended receptor cross‑talk or inhibitory signal interference
  • Cytoskeletal destabilisation and membrane‑integrity reduction
  • Dose‑dependent cytotoxicity or programmed‑cell‑death activation
  • Transcriptional and epigenetic instability
  • Inflammatory‑cascade activation (NF‑κB, MAPK, JNK)

Datasheet


Molecular Formula

C28H38O7

Molecular Weight

486.6 g/mol

CAS Number

915297-18-8

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

1229022-83-6

IUPAC/Chemical Name

Human IgG1 monoclonal antibody

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download